Ausgabe 8/2015
Inhalt (8 Artikel)
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
Celina S. Liu, Sarah A. Chau, Myuri Ruthirakuhan, Krista L. Lanctôt, Nathan Herrmann
Pharmacological Management of Opioid Use Disorder in Pregnant Women
Christine M. Wilder, Theresa Winhusen
The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
Marc De Hert, Jan Sermon, Paul Geerts, Kristof Vansteelandt, Joseph Peuskens, Johan Detraux
Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Gyanendra Kumar, Drew Uhrig, Susan Fowler, Matthew C. DeLaney, Andrei V. Alexandrov
Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects
Gail D. Anderson, Russell P. Saneto
Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy
Ann C. Childress, Floyd R. Sallee
Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants
Ai Leng Khoo, Hui Jun Zhou, Monica Teng, Liang Lin, Ying Jiao Zhao, Lay Beng Soh, Yee Ming Mok, Boon Peng Lim, Kok Peng Gwee
Erratum to: Oxycodone/Naloxone PR: A Review in Severe Refractory Restless Legs Syndrome
James E. Frampton